Bioanalytical Services
At C₂N Diagnostics, we are leading ways to provide new insights into the molecular mechanisms of brain diseases, track early progression, and measure the biologic activity of emerging therapies.
Bioanalytical Services
Preclinical
In vitro kinetic assays for drug screening Studies on a variety of animal models Lead candidate selection and/or validation
Phase I/IIa
Target engagement Dose optimization and scheduling Single and multiple dosing
Phase II
Mild cognitive impairment/AD PK/PD correlations Responders versus non-responders
Phase III/IV
Adaptive drug trials Drug responders Clinical endpoint validation (PD correlations)
Research Studies
Researchers: C₂N partners with many academic and research institutions interested in using C₂N neurodegenerative biomarkers in pre-clinical and clinical research studies (e.g., Alzheimer’s disease). If you wish to discuss C₂N biomarkers or the use of the PrecivityAD™ test in your research studies, please complete the following form. A C₂N representative will be in contact once your information has been received.
For immediate questions, please reach out at research@c2n.com or call 1.877.226.3424.